Cargando…
Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study
BACKGROUND: Standard treatment of advanced ovarian cancer is surgery and chemotherapy. The goal of surgery is to remove all macroscopic tumour, as the amount of residual tumour is the most important prognostic factor for survival. When removal off all tumour is considered not feasible, neoadjuvant c...
Autores principales: | Rutten, Marianne J, Gaarenstroom, Katja N, Van Gorp, Toon, van Meurs, Hannah S, Arts, Henriette JG, Bossuyt, Patrick M, Ter Brugge, Henk G, Hermans, Ralph HM, Opmeer, Brent C, Pijnenborg, Johanna MA, Schreuder, Henk WR, Schutter, Eltjo MJ, Spijkerboer, Anje M, Wensveen, Celesta WM, Zusterzeel, Petra, Mol, Ben Willem J, Kenter, Gemma G, Buist, Marrije R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292486/ https://www.ncbi.nlm.nih.gov/pubmed/22264278 http://dx.doi.org/10.1186/1471-2407-12-31 |
Ejemplares similares
-
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study
por: van de Laar, Rafli, et al.
Publicado: (2014) -
Craniocaudal tumour extension in uterine cervical cancer on MRI compared to histopathology
por: de Boer, Peter, et al.
Publicado: (2015) -
Ov2 is a modulator of OvHV-2 RTA mediated gene expression
por: Dry, Inga, et al.
Publicado: (2019) -
Nouveau coronavirus (NcOV)
por: Bricaire, François
Publicado: (2013) -
Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)